List view / Grid view
13 April 2016 | By Victoria White, Digital Content Producer
The sBLA is for patients with recurrent or metastatic head and neck squamous cell carcinoma with disease progression on or after platinum-containing chemotherapy...
13 April 2016 | By Victoria White, Digital Content Producer
Results from the Phase IIb LUX-Lung 7 trial showed that afatinib significantly reduced the risk of lung cancer progression by 27% versus gefitinib...
13 April 2016 | By Victoria White, Digital Content Producer
NICE has issued guidance advising the best ways of ensuring controlled drugs such as morphine, methadone and diazepam are used safely and responsibly...
13 April 2016 | By Victoria White, Digital Content Producer
The FDA has approved Epigenomics’ lead product, Epi proColon, the first and only FDA-approved blood-based colorectal cancer screening test...
13 April 2016 | By Victoria White, Digital Content Producer
A study has shown that the 'prime boost' approach is compatible with co-administration of vectors encoding for HIV and HCV antigens...
12 April 2016 | By Victoria White, Digital Content Producer
HinsBet is a rapid-acting formulation of recombinant human insulin using BioChaperone, which is designed to accelerate insulin absorption...
12 April 2016 | By Victoria White, Digital Content Producer
Venclexta is the first FDA-approved treatment that targets the BCL-2 protein, which supports cancer cell growth and is overexpressed in many CLL patients...
12 April 2016 | By Victoria White, Digital Content Producer
Everolimus for advanced breast cancer, savuconazole for invasive aspergillosis and mucormycosis, and camellia sinensis for genital warts were all accepted...
12 April 2016 | By Victoria White, Digital Content Producer
The randomised, double-blind Phase II clinical study is designed to evaluate the safety and efficacy of Bekinda 12 mg in patients suffering from IBS-D...
11 April 2016 | By Victoria White, Digital Content Producer
Medical professionals, businesses and government officials from around the world have declared their commitment to fight antimicrobial resistance at ECCMID...
11 April 2016 | By Victoria White, Digital Content Producer
A current lack of data on outcomes in patients with IBD who have CDI means that appropriate choice of treatment strategy can be unclear...
11 April 2016 | By Victoria White, Digital Content Producer
TSC is the third indication that GW is targeting with Epidiolex, which includes four Phase III trials in Dravet syndrome and Lennox-Gastaut syndrome...
11 April 2016 | By Victoria White, Digital Content Producer
The first cancer patient in Europe has been scanned with a imaging technique that could enable doctors to see whether a drug is working within a day of starting treatment...
11 April 2016 | By Victoria White, Digital Content Producer
The FDA has granted a priority review for atezolizumab for the treatment of locally advanced or metastatic NSCLC that expresses the protein PD-L1...
8 April 2016 | By Victoria White, Digital Content Producer
The CHMP has recommended approval of a type II variation to include data from the TERRAIN trial of Xtandi (enzalutamide) versus bicalutamide...
